METHYLMALONIC ACIDEMIA (MMA)
Clinical trials for METHYLMALONIC ACIDEMIA (MMA) explained in plain language.
Never miss a new study
Get alerted when new METHYLMALONIC ACIDEMIA (MMA) trials appear
Sign up with your email to follow new studies for METHYLMALONIC ACIDEMIA (MMA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with rare MMA: B12 shot trial aims to tame toxic acids
Disease control Not yet recruitingThis study tests a vitamin B12 injection (hydroxocobalamin) in 20 children aged 6 months to 18 years with a rare genetic condition called methylmalonic acidemia (MMA) with high homocysteine. The goal is to see if the injection can normalize harmful acid levels in the blood or uri…
Matched conditions: METHYLMALONIC ACIDEMIA (MMA)
Phase: PHASE3 • Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 13:14 UTC
-
New study aims to unlock clues for rare childhood disease
Knowledge-focused Not yet recruitingThis study follows up to 30 children (up to age 16) with a rare genetic condition called methylmalonic acidemia (MMA). The goal is to track how the disease progresses over time by looking at blood tests and other health signs. No new treatments are tested here; instead, the infor…
Matched conditions: METHYLMALONIC ACIDEMIA (MMA)
Sponsor: Genespire Srl • Aim: Knowledge-focused
Last updated May 20, 2026 11:56 UTC